Starke Clifford 4
4 · Flora Growth Corp. · Filed Sep 6, 2024
Insider Transaction Report
Form 4
Starke Clifford
DirectorCEO
Transactions
- Purchase
Common Shares
2024-09-05$0.95/sh+51$48→ 474,046 total - Award
Stock Appreciation Rights ("SARs")
2023-12-15+1,028,665→ 1,028,665 totalExercise: $1.21Exp: 2033-12-15→ Common Shares (1,028,665 underlying) - Award
Stock Appreciation Rights ("SARs")
2024-08-14+575,319→ 575,319 totalExercise: $0.92Exp: 2034-08-14→ Common Shares (575,319 underlying)
Holdings
- 300,347(indirect: See footnote)
Common Shares
- 565,714(indirect: See footnote)
Common Shares
Footnotes (3)
- [F1]Held by YT Research, Inc., a company in which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by YT Research, Inc. except to the extent of his pecuniary interest therein.
- [F2]Held by Hampstead Private Capital Limited, a company in which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by Hampstead Private Capital Limited except to the extent of his pecuniary interest therein.
- [F3]The SARs vest in 12 equal installments, subject to stock price criteria to be met prior to each tranche vesting. The SARs have a post-termination exercise period of one year.